Ixazomib
ATC L01XG03 · 11 markets · 37 records
GB 9 records · 3 shown of 3
US 3 records · 3 shown of 3
CA 3 records · 3 shown of 3
AU 3 records · 3 shown of 3
- 5.7 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack
- 4.3 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack
- 3.29 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack
SG 3 records · 3 shown of 3
CN 3 records · 3 shown of 3
TW 3 records · 3 shown of 3
HK 3 records · 0 shown of 0
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 3 records · 3 shown of 3
- 5.7 mgcapsuleNINLARO 2,3 mg, gélule
- 4.3 mgcapsuleNINLARO 2,3 mg, gélule
- 3.3 mgcapsuleNINLARO 2,3 mg, gélule
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | CN | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 mg capsule | NINLARO | Manufacturer: Takeda UK Ltd ×3 NINLARO | NINLARO | NINLARO | 恩莱瑞枸橼酸伊沙佐米 | NINLARO 免瘤諾 膠囊4毫克 | ||||
| 3 mg capsule | NINLARO | Manufacturer: Takeda UK Ltd ×3 NINLARO | NINLARO | NINLARO | 恩莱瑞枸橼酸伊沙佐米 | NINLARO 免瘤諾 膠囊3毫克 | ||||
| 2.3 mg capsule | NINLARO | Manufacturer: Takeda UK Ltd ×3 NINLARO | NINLARO | NINLARO | 恩莱瑞枸橼酸伊沙佐米 | NINLARO 免瘤諾 膠囊2.3毫克 | ||||
| 5.7 mg capsule | NINLARO ixazomib (as citrate) 4mg capsule blister pack | NINLARO 2,3 mg, gélule | ||||||||
| 4.3 mg capsule | NINLARO ixazomib (as citrate) 4mg capsule blister pack | NINLARO 2,3 mg, gélule | ||||||||
| 3.3 mg capsule | NINLARO 2,3 mg, gélule | |||||||||
| 3.29 mg capsule | NINLARO ixazomib (as citrate) 4mg capsule blister pack | |||||||||
unknown | NINLARO | NINLARO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
5 more strength/form rows are recorded only in AU · HK · EU · FR and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en AU · HK · EU · FR que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 AU · HK · EU · FR 有记录（未在本表显示）。 另有 5 個規格/劑型僅在 AU · HK · EU · FR 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.